SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 356 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.86 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $42,450,000 | -27.0% | 369,325 | -0.8% | 1.84% | -26.0% |
Q3 2014 | $58,164,000 | +34.9% | 372,275 | +6.5% | 2.48% | +63.9% |
Q2 2014 | $43,128,000 | +6.2% | 349,640 | -10.8% | 1.52% | +4.2% |
Q1 2014 | $40,620,000 | -0.5% | 392,050 | -13.7% | 1.46% | +3.3% |
Q4 2013 | $40,842,000 | +19.0% | 454,100 | -11.5% | 1.41% | +21.4% |
Q3 2013 | $34,323,000 | -17.2% | 513,200 | -18.1% | 1.16% | -30.8% |
Q2 2013 | $41,463,000 | – | 626,800 | – | 1.68% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Verition Fund Management LLC | 2,787,800 | $481,760,000 | 55.98% |
Brenner West Capital Advisors | 1,800,000 | $311,058,000 | 28.01% |
FNY Managed Accounts LLC | 180,357 | $31,167,493,000 | 25.70% |
Twin Securities, Inc. | 1,189,192 | $205,505,000 | 24.16% |
FIRST NEW YORK SECURITIES LLC /NY | 98,099 | $16,952,488,000 | 16.70% |
HARVEST MANAGEMENT LLC | 77,500 | $13,393,000 | 14.40% |
Tyrus Capital S.A.M. | 687,800 | $118,859,000 | 13.24% |
BARDIN HILL MANAGEMENT PARTNERS LP | 472,550 | $81,661,000 | 11.65% |
ARGENTIERE CAPITAL AG | 151,500 | $26,181,000 | 10.81% |
Sachem Head Capital | 725,000 | $125,425,000 | 8.31% |